German Dementia Registry

Recruiting

• Conditions: F03; F00; F01; F02; G20; Unspecified dementia; Dementia in Alzheimer disease; Vascular dementia; Dementia in other diseases classified elsewhere; Parkinson disease

• Registration Number: DRKS00027547
• Lead Sponsor: Klinik für Neurologie des Uniklinikums Aachen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Ability of the participant and/or his/her legally authorized representative (e.g., spouse or legal guardian), as appropriate and applicable, to understand the purpose and risks of the register and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local privacy regulations.

Participating patients must have a diagnosis of SCI, MCI, early dementia, moderate dementia or severe dementia of different etiology (i.e. Alzheimer’s Disease, Frontotemporal Dementia, Parkinson’s Disease, Lewy-Body Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Normal Pressure Hydrocephalus, Major Depression; Vascular Dementia; TDP-43 associated limbic encephalopathy (LATE), Mixed Dementia AD + VaD, Prion-Associated Dementia) with fluid and/or imaging biomarkers.

At least 18 years of age.

Inclusion Criteria for familiy member:

At least 18 years of age.
Patient was included in the registry
Family member is strongly involved to the patient's life according to the patient’s statement
Ability of the participant, as appropriate and applicable, to understand the purpose and risks of the register

Exclusion Criteria

Unable or unwilling to provide informed consent.

No available biomarkers such as cerebrospinal fluids (CSF) amyloid beta 1-42, amyloid beta 1-40, amyloid beta 1-42/amyloid beta 1-40 ratio, total tau and phospho-tau, amyloid or tau imaging.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To create a registry to collecting longterm data on patients with cognitive impairment and early dementia and the impact of treatments.

Secondary Outcome Measures

Name	Time	Method
ot applicable